Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System

OBJECTIVES: Paclitaxel is a highly effective antitumor agent with notable adverse events, including hypersensitivity reactions, peripheral neuropathy, arthralgia, myalgias, and neutropenia. Solvent-based paclitaxel causes severe allergic, hypersensitivity, and anaphylactic reactions. Nanoparticle al...

Descripción completa

Detalles Bibliográficos
Autores principales: Naganuma, Misa, Tahara, Kohei, Hasegawa, Shiori, Fukuda, Akiho, Sasaoka, Sayaka, Hatahira, Haruna, Motooka, Yumi, Nakao, Satoshi, Mukai, Ririka, Hirade, Kouseki, Yoshimura, Tomoaki, Kato, Takeshi, Takeuchi, Hirofumi, Nakamura, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413422/
https://www.ncbi.nlm.nih.gov/pubmed/30886713
http://dx.doi.org/10.1177/2050312119836011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413422/
https://www.ncbi.nlm.nih.gov/pubmed/30886713
http://dx.doi.org/10.1177/2050312119836011

Ejemplares similares